Letter to the editor: Comment on "Cardiometabolic benefits of Lacticaseibacillus paracasei 8700:2: A randomized double-blind placebo-controlled trial".

Linghui Tao, Zhangchenyang Wang, Jinhan Chen, Mingxian Chen

Journal: Clinical nutrition (Edinburgh, Scotland) 2024;43(1):302-303

PMID: 37993388

Full Text on Elsevier Science View on PubMed

Abstract

Address: Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang Province, China.; Department of Gastroenterology, Tongde Hospital of Zhejiang Province, Street Gucui No.234, Region Xihu, Hangzhou 310012, Zhejiang Province, China. Electronic address: [email protected].

DOI: 10.1016/j.clnu.2023.11.017

Link outs

Subscription / membership required

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S0261...
https://www.clinicalkey.com/content/playBy/pii?v=S...

MeSH Terms: Humans, Cardiovascular Diseases, Double-Blind Method, Lacticaseibacillus paracasei, Probiotics, Randomized Controlled Trials as Topic